+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Supply & Logistics Market by Services, Type, Phase, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
Clinical Trial Supply & Logistics Market by Services, Type, Phase, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
Sale

Clinical Trial Supply & Logistics Market by Services, Type, Phase, Therapeutic Area, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5470856
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trial Supply & Logistics Market grew from USD 24.33 billion in 2023 to USD 26.20 billion in 2024. It is expected to continue growing at a CAGR of 7.75%, reaching USD 41.04 billion by 2030.

The clinical trial supply and logistics market involves the management and transportation of materials critical for clinical trial operations, including investigational medicinal products, lab kits, and documents. Primarily driven by the increasing number and complexity of clinical trials, the market is indispensable for ensuring the timely and effective distribution of supplies to global trial sites. Its application spans from the pharmaceutical industry to biotechnology and medical device sectors, enabling smooth operations in drug development. The end-users include pharmaceutical companies, contract research organizations (CROs), and clinical research institutions that rely on sophisticated logistics solutions to maintain the integrity of trial materials and meet regulatory standards. Key growth factors include the surge in clinical trials due to rising chronic disease prevalence, innovations in personalized medicine, and advancements in biotechnology. The increasing adoption of technologies like blockchain for traceability and artificial intelligence for logistical planning represents significant opportunities. Companies can capitalize by investing in integrated solutions that enhance transparency, predict demand, and optimize supply chains. However, market growth faces constraints such as stringent regulatory compliances, high costs associated with handling perishable goods, and logistical complexities intensified by the global reach of modern trials. Further limitations include geopolitical uncertainties affecting cross-border logistics and a shortage of skilled professionals to manage sophisticated supply chain technologies. For business growth, innovation areas include the development of robust cold chain logistics solutions, adoption of digital twins for supply chain forecasting, and automation of data management processes to improve efficacy and reduce errors. The market is naturally competitive, driven by the need for constant innovation and adherence to high-quality standards to maintain product integrity. Companies that can integrate digital technologies with traditional logistics practices and offer comprehensive, agile solutions stand to benefit the most in this evolving landscape.

Understanding Market Dynamics in the Clinical Trial Supply & Logistics Market

The Clinical Trial Supply & Logistics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
    • Globalization of clinical trials and harmonization of regulations
  • Market Restraints
    • Problems associated with technology integration and data management
  • Market Opportunities
    • Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
    • Increasing partnership activities between pharmaceutical manufacturers and CDMOs
  • Market Challenges
    • Concerns associated with the operations within clinical trial supply and logistics

Exploring Porter’s Five Forces for the Clinical Trial Supply & Logistics Market

Porter’s Five Forces framework further strengthens the insights of the Clinical Trial Supply & Logistics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Clinical Trial Supply & Logistics Market

External macro-environmental factors deeply influence the performance of the Clinical Trial Supply & Logistics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Clinical Trial Supply & Logistics Market

The Clinical Trial Supply & Logistics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Clinical Trial Supply & Logistics Market

The Clinical Trial Supply & Logistics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Services
    • Comparator Sourcing
    • Logistics & Distribution
      • Cold Chain Distribution
      • Non-Cold Chain Distribution
    • Manufacturing
    • Packaging, Labeling, & Blinding
    • Storage & Retention
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small Molecules
  • Phase
    • BA/ BE studies
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Therapeutic Area
    • Blood Disorders
    • Cardiovascular Diseases
    • CNS & Mental Disorders
    • Dermatological Disorders
    • Digestive Disorders
    • ENT Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Nephrology
    • Oncology
    • Rare Diseases
    • Respiratory Disorders
  • End User
    • Contract Research Organisations
    • Medical Devices Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • Massachusetts
        • Minnesota
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
5.1.1.2. Globalization of clinical trials and harmonization of regulations
5.1.2. Restraints
5.1.2.1. Problems associated with technology integration and data management
5.1.3. Opportunities
5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
5.1.4. Challenges
5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
5.2. Market Segmentation Analysis
5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
5.5.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
5.5.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
5.5.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
5.5.4. Eurofins Scientific Group: Eurofins Scientific Group’s focus on conferences and fairs for effective product marketing
5.5.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
5.5.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
5.5.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
5.5.8. Small Molecules: Need to address intense competition and regulatory complexities
5.5.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services
6. Clinical Trial Supply & Logistics Market, by Services
6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
6.3.1. Cold Chain Distribution
6.3.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention
7. Clinical Trial Supply & Logistics Market, by Type
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules
8. Clinical Trial Supply & Logistics Market, by Phase
8.1. Introduction
8.2. BA/ BE studies
8.3. Phase 1
8.4. Phase 2
8.5. Phase 3
8.6. Phase 4
9. Clinical Trial Supply & Logistics Market, by Therapeutic Area
9.1. Introduction
9.2. Blood Disorders
9.3. Cardiovascular Diseases
9.4. CNS & Mental Disorders
9.5. Dermatological Disorders
9.6. Digestive Disorders
9.7. ENT Diseases
9.8. Immunology
9.9. Infectious Diseases
9.10. Metabolic Disorders
9.11. Nephrology
9.12. Oncology
9.13. Rare Diseases
9.14. Respiratory Disorders
10. Clinical Trial Supply & Logistics Market, by End User
10.1. Introduction
10.2. Contract Research Organisations
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Clinical Trial Supply & Logistics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Supply & Logistics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
14.3.10. Vial Announces Strategic Partnership with Royale International Group
14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 64. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 68. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 99. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 103. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 105. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 106. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 151. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 153. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 154. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 157. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 176. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 178. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 179. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 184. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 185. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 187. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 188. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 191. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 194. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 206. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 208. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 209. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 224. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 226. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 227. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 230. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 232. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 233. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 235. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 236. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 238. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 239. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 259. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 263. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 274. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 275. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 277. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 280. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 281. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 292. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 295. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Clinical Trial Supply & Logistics market, which are profiled in this report, include:
  • Acnos Pharma GmbH
  • ADAllen Pharma Ltd
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Calyx
  • Catalent, Inc.
  • Clinical Services International LTD
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • DHL Group
  • Eurofins Scientific SE
  • Experic, LLC
  • FedEx Corporation
  • ICON PLC
  • Inceptua S.A.
  • Infosys Limited
  • IPS Pharma
  • KLIFO A/S
  • Lonza Group AG
  • Marken Limited by United Parcel Service, Inc.
  • Microsoft Corporation
  • Myonex, Inc.
  • N-SIDE SA
  • NUVISAN GmbH
  • OCT Clinical GmbH
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Limited
  • Recipharm AB
  • SAP SE
  • Sharp Services, LLC
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc.
  • Tower Cold Chain Solutions
  • Uniphar PLC
  • Walden Group
  • Zuellig Pharma Pte Ltd by Interpharma Investments Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 26.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 41.04 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned43

Related Topics

Related Reports

Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 137 Pages
  • Global
From
Clinical Trial Supplies Market by Phase, ????, Product, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Clinical Trial Supplies Market by Phase, ????, Product, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 131 Pages
  • Global
From
Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2024-2032 - Product Image

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.